Stemtech (STEK) EPS (Weighted Average and Diluted) (2021 - 2025)

Stemtech has disclosed EPS (Weighted Average and Diluted) across 5 years of filings, most recently posting -$0.01 for Q4 2025.

• EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.01, down 161.25% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.02 (up 50.0% YoY), and the FY2025 annual result was -$0.02, up 33.33% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.01 for Q4 2025 at Stemtech, up from -$0.01 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.38 in Q3 2022 to a low of -$0.56 in Q2 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.01 (2022), against an average of -$0.02.
• Peak annual rise in EPS (Weighted Average and Diluted) reached 235.71% in 2022, while the deepest fall reached 2700.0% in 2022.
• Stemtech's EPS (Weighted Average and Diluted) stood at $0.27 in 2021, then sank by 103.7% to -$0.01 in 2022, then plunged by 100.0% to -$0.02 in 2023, then jumped by 83.29% to -$0.0 in 2024, then tumbled by 161.25% to -$0.01 in 2025.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.01 (Q4 2025), -$0.01 (Q3 2025), and -$0.0 (Q2 2025), per Business Quant data.